|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 8.990 SEK | +0.11% |
|
+1.93% | -33.41% |
| 08-13 | Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan | FW |
| 08-13 | Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIVESTO AB | Other Pharmaceuticals | +0.11% | +1.93% | -33.41% | -59.60% | -96.68% | 10.27M |  | | |
- Stock Market
- Stocks
- VIVE Stock
- Charts Vivesto AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
